Literature DB >> 26739464

[The guideline of prevention and treatment for chronic hepatitis B: a 2015 update].

Jin-Lin Hou1, Wei lai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26739464     DOI： 10.3760/cma.j.issn.1007-3418.2015.12.002

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN： 1007-3418


× No keyword cloud information.
  75 in total

1.  Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China.

Authors:  Keng Lai; Chi Zhang; Weixia Ke; Yanhui Gao; Shudong Zhou; Li Liu; Yi Yang
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

Review 2.  Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs.

Authors:  Fengmin Lu; Jie Wang; Xiangmei Chen; Dongping Xu; Ningshao Xia
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

Review 3.  Current advances in the elimination of hepatitis B in China by 2030.

Authors:  Shuye Zhang; Fusheng Wang; Zheng Zhang
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

4.  Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016).

Authors:  Hong-Yu Zhang; Long-Gen Liu; Chun-Yan Ye; Chun-Hua Chen; Shuang-Xiong Hang; Zhen Zhu; Hong-Yu Shen; Ze-Yu Huang; Wen-Yi Chen; Yuan Xue
Journal:  Virus Genes       Date:  2017-11-08       Impact factor: 2.332

5.  Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a.

Authors:  Ming-Hui Li; Yao Xie; Lu Zhang; Yao Lu; Ge Shen; Shu-Ling Wu; Min Chang; Cai-Qin Mu; Lei-Ping Hu; Wen-Hao Hua; Shu-Jing Song; Shu-Feng Zhang; Jun Cheng; Dao-Zhen Xu
Journal:  World J Hepatol       Date:  2016-05-28

6.  [Incidence and characteristics of benign liver space-occupying mass in 17 721 patients with chronic hepatitis B: a color Doppler ultrasound-based case-control study].

Authors:  Yanyu Ren; Guosheng Yuan; Yuchen Zhou; Chengguang Hu; Junwei Liu; Muhammad Ikram Anwar; Cuirong Tang; Yuan Li; Wenxuan Yu; Yuanping Zhou; Lin Lin Dai
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

7.  Chinese guidelines on the management of ascites and its related complications in cirrhosis.

Authors:  Xiaoyuan Xu; Zhongping Duan; Huiguo Ding; Wengang Li; Jidong Jia; Lai Wei; Enqiang Linghu; Hui Zhuang
Journal:  Hepatol Int       Date:  2019-01-18       Impact factor: 6.047

8.  New Gene Variants Associated with the Risk of Chronic HBV Infection.

Authors:  Mengjie Fan; Jing Wang; Sa Wang; Tengyan Li; Hong Pan; Hankui Liu; Huifang Xu; Daria V Zhernakova; Stephen J O'Brien; Zhenru Feng; Le Chang; Erhei Dai; Jianhua Lu; Hongli Xi; Yanyan Yu; Jianguo Zhang; Binbin Wang; Zheng Zeng
Journal:  Virol Sin       Date:  2020-04-15       Impact factor: 4.327

9.  Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Zheng Li; Zhengqing Lei; Yong Xia; Jun Li; Kui Wang; Han Zhang; Xuying Wan; Tian Yang; Weiping Zhou; Mengchao Wu; Timothy M Pawlik; Wan Yee Lau; Feng Shen
Journal:  JAMA Surg       Date:  2018-10-17       Impact factor: 14.766

Review 10.  Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.

Authors:  Da-Wu Zeng; Jing Dong; Yu-Rui Liu; Jia-Ji Jiang; Yue-Yong Zhu
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.